查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
成像临床研究机构市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按提供的服务、成像方式、临床试验阶段、应用、终端用户、公司和地区分类
市场调查报告书
商品编码
1303139

成像临床研究机构市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按提供的服务、成像方式、临床试验阶段、应用、终端用户、公司和地区分类

Imaging Clinical Research Organization Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2017-2027 Segmented By Services Offered, By Imaging Modality, By Clinical Trial Phase, By Application, By End User, By company & By Region
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在2023-2027年的预测期内，全球影像临床研究机构（CRO）市场预计将出现令人瞩目的增长。主要因素包括临床试验数量的增长，研发支出的持续增长，以及技术的广泛进步正在推动市场的增长。医学成像在新型生命科学产品的临床进展中发挥着有效作用。生物技术和制药业的扩张，以及为开发治疗各种疾病的新药而增加的研发投资，可能会推动市场行业增长。支持市场增长的其他因素是，研发活动的增加，研发支出的增加，成像过程自动化的增加，成像技术使用的增加和计算能力的增强，以及合并和战略收购数量的增加。

医学成像的年度临床试验数量增加支持市场增长。

由于临床研究的增加，临床试验的数量不断增加，促进了市场的增长。成像临床研究机构通过提供大量的信息和对关键领域的洞察力来帮助研究人员。他们正在为医疗设备、生物技术和制药等各种行业增加质量、成本效益和制造能力。医学成像在临床试验中的意义越来越大，推动了市场的增长。根据Keosys医学影像的文章，2018年，每年进行的临床试验总数在2020年比2010年几乎翻了一番。

研发活动和支出的增长促进市场增长

研究和开发（R&D）活动的增加正在促进市场的增长。放射学和成像科学领域的研究不断增加，有助于产生关键技术，并磨练出使用设备识别和治疗人类异常和疾病的现代技术。如今，在医学成像的帮助下，各种临床研究被用来评估医疗、手术和行为干预。另外，研发支出的持续增长也促进了市场的增长。

在成像CRO过程中越来越多地采用自动化

在过去的几年里，技术的快速进步正在推动市场的增长。影像学CRO过程中的自动化等进步正在对生物技术和制药业产生巨大影响。成像CRO过程中的自动化使该过程有效和高效；同时，它也有助于控制错误和减少时间。因此，成像过程中越来越多地采用自动化，鼓励了市场的增长。例如，2021年，雅培公司宣布其最新的光学相干断层扫描（OCT）成像平台获得了FDA的许可，该平台由该公司新的Ultreon软件操作。这种先进的成像软件将OCT与人工智能相结合，为医生提供了一个增强的、全面的冠状动脉血流和堵塞物的视图，以帮助医生决策并提供最佳的治疗路线。

可用的定制方案

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告有以下定制选项：

公司信息

  • 其他市场参与者（最多5家）的详细分析和概况。

目录

第一章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19对全球影像临床研究组织（CRO）市场的影响

第五章：客户的声音

第六章：全球影像学临床研究组织（CRO）市场展望

  • 市场规模与预测
    • 按价值计算
  • 市场份额与预测
    • 按提供的服务（成像采集和方案开发、应用设计、图像采集和质量控制、数字图像转换、支持和维护、其他）分类
    • 按成像方式（计算机断层扫描（CT）、磁共振成像（MRI）、正电子发射断层扫描（PET）、其他）分类
    • 按临床试验阶段（第1阶段、第2阶段、第3阶段）
    • 按应用（肿瘤学、神经学、心血管学、眼科、其他）分类
    • 按终端用户（制药和生物技术公司、医疗设备制造商、学术和研究机构、其他）
    • 按地区
    • 按公司分类（2021年）
  • 市场地图

第七章：北美影像临床研究组织（CRO）市场前景

  • 市场规模与预测
    • 按价值分类
  • 市场份额与预测
    • 按提供的服务分类
    • 按成像方式分类
    • 按临床试验阶段分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 美国
    • 墨西哥

第八章：欧洲影像临床研究组织（CRO）市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按提供的服务分类
    • 按成像方式分类
    • 按临床试验阶段分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第九章：亚太地区影像临床研究组织（CRO）市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按提供的服务分类
    • 按成像方式分类
    • 按临床试验阶段分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章：南美影像临床研究组织（CRO）市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按提供的服务分类
    • 按成像方式分类
    • 按临床试验阶段分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 ：中东和非洲影像临床研究组织（CRO）市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按提供的服务分类
    • 按成像方式分类
    • 按临床试验阶段分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • MEA: 国家分析
    • 南非影像学临床研究组织(CRO)
    • 沙特阿拉伯 影像学临床研究组织（CRO）
    • 阿联酋 影像学临床研究组织(CRO)
    • 土耳其 影像学临床研究组织(CRO)
    • 埃及 影像学临床研究组织(CRO)

第十二章 ：市场动态

  • 驱动力
  • 挑战

第十三章 ：市场趋势与发展

第十四章：竞争格局

  • 美国实验室公司控股 IXICO PLC ICON plc The Micron Group Medpace Holdings, Inc.Radiant Sage LLC Biomedical Systems Corporation Worldcare Clinical, LLC Imaging Endpoints LLC Parexel International Corporation

第十五章：战略建议

简介目录
Product Code: 14156

The global imaging clinical research organization (CRO) market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the growing number of clinical trials, continuous growth in R&D spending, and extensive advancement in technology are impelling the growth of the market. Medical imaging plays an effective role in the clinical advancement of novel life science products. The expansion of the biotechnology and pharmaceutical industries, along with increased research and development investments for developing new drugs to treat various diseases, is likely to drive the market industry growth. The other factors supporting the market's growth are, rise in R&D activities, increasing R&D expenditure, a rise in automation of imaging process, increasing usage of imaging technology and the enhanced power of computing, and a growing number of mergers and strategic acquisitions.

An increase in the Annual Number of Clinical Trials with Medical Imaging supports Market Growth.

A growing number of clinical trials due to the rise in clinical research is augmenting the growth of the market. Imaging Clinical Research Organizations help researchers by providing massive amounts of information and insights into key areas. They are adding quality, cost-effectiveness, and manufacturing capacity to various industries such as medical devices, biotechnology, and pharmaceutical. The growing significance of medical imaging in clinical trials is fueling the growth of the market. According to a Keosys Medical Imaging article, in 2018, the total number of clinical trials performed each year almost doubled in 2020 compared to 2010.

Growth in R&D Activities and spending to foster the Market Growth

The rise in research and development (R&D) activities is bolstering the growth of the market. Rising research in the field of radiology and imaging sciences are helping to generate critical technologies, as well as honed modern techniques for using equipment to identify and treat abnormalities and disease in humans. Nowadays, various clinical studies are done to evaluate medical, surgical, and behavioral interventions with the help of medical imaging. Also, continuous growth in R&D spending is facilitating the growth of the market.

Increasing Adoption of Automation in Imaging CRO Process

Over the past few years, rapid advancements in technology are propelling the growth of the market. Advancements such as automation in the Imaging CRO process are making a huge impact on the biotechnology and pharmaceutical industries. Automation in the imaging CRO process makes the process effective and efficient; also, it helps to control errors and minimize time. Thus, the increasing adoption of automation in the imaging process encourages the growth of the market. For instance, in 2021, Abbott announced that it had received FDA clearance for the latest optical coherence tomography (OCT) imaging platform operated by the company's new Ultreon Software. This advanced imaging software combines OCT with artificial intelligence to offer physicians an enhanced, comprehensive view of coronary blood flow and blockages to aid physician decision-making and offer the best route for treatment.

Market Segmentation

The global imaging clinical research organization (CRO) market is segmented into services offered, imaging modality, clinical trial phase, application, end user, and company. Based on the services offered, the market is divided into imaging acquisition and protocol development, application design, image collection, and quality control, digital image conversion, support and maintenance, and others. Based on imaging modality, the market is divided into computed tomography (CT) scans, magnetic resonance imaging (MRI), positron emission tomography (PET), and others. Based on the clinical trial phase, the market is divided into Phase 1, phase 2, and Phase 3. Based on application, the market is divided into oncology, neurology, cardiovascular, ophthalmology, and others. Based on end-user, the market is divided into pharmaceutical & biotechnology companies, medical device manufacturers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of clinical studies in the country.

Market Players

Laboratory Corporation of America Holdings, IXICO PLC, ICON plc, The Micron Group, Medpace Holdings, Inc., Radiant Sage LLC, Biomedical Systems Corporation, Worldcare Clinical, LLC, Imaging Endpoints LLC, and Parexel International Corporation are some of the leading companies operating in the market.

Report Scope

In this report, global imaging clinical research organization (CRO) market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Imaging Clinical Research Organization (CRO) Market, By Services Offered:

  • Imaging Acquisition and Protocol Development
  • Application Design
  • Image Collection and Quality Control
  • Digital Image Conversion
  • Support and Maintenance
  • Others

Imaging Clinical Research Organization (CRO) Market, By Imaging Modality:

  • Computed Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Others

Imaging Clinical Research Organization (CRO) Market, By Clinical Trial Phase:

  • Phase 1
  • Phase 2
  • Phase 3

Imaging Clinical Research Organization (CRO) Market, By application:

  • Oncology
  • Neurology
  • Cardiovascular
  • Ophthalmology
  • Others

Imaging Clinical Research Organization (CRO) Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Academic & Research Institutions
  • Others

Imaging Clinical Research Organization (CRO) Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Imaging Clinical Research Organization (CRO) Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Imaging Clinical Research Organization (CRO) Market

5. Voice of Customer

6. Global Imaging Clinical Research Organization (CRO) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Services Offered (Imaging Acquisition and Protocol Development, Application Design, Image Collection and Quality Control, Digital Image Conversion, Support and Maintenance, Others)
    • 6.2.2. By Imaging Modality (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Others)
    • 6.2.3. By Clinical Trial Phase (Phase 1, Phase 2, Phase 3)
    • 6.2.4. By Application (Oncology, Neurology, Cardiovascular, Ophthalmology, Others)
    • 6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic & Research Institutions, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Imaging Clinical Research Organization (CRO) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Services Offered
    • 7.2.2. By Imaging Modality
    • 7.2.3. By Clinical Trial Phase
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Services Offered
        • 7.3.1.2.2. By Imaging Modality
        • 7.3.1.2.3. By Clinical Trial Phase
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Services Offered
        • 7.3.2.2.2. By Imaging Modality
        • 7.3.2.2.3. By Clinical Trial Phase
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Imaging Clinical Research Organization (CRO) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Services Offered
        • 7.3.3.2.2. By Imaging Modality
        • 7.3.3.2.3. By Clinical Trial Phase
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Imaging Clinical Research Organization (CRO) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Services Offered
    • 8.2.2. By Imaging Modality
    • 8.2.3. By Clinical Trial Phase
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Services Offered
        • 8.3.1.2.2. By Imaging Modality
        • 8.3.1.2.3. By Clinical Trial Phase
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Services Offered
        • 8.3.2.2.2. By Imaging Modality
        • 8.3.2.2.3. By Clinical Trial Phase
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Services Offered
        • 8.3.3.2.2. By Imaging Modality
        • 8.3.3.2.3. By Clinical Trial Phase
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Services Offered
        • 8.3.4.2.2. By Imaging Modality
        • 8.3.4.2.3. By Clinical Trial Phase
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Imaging Clinical Research Organization (CRO) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Services Offered
        • 8.3.5.2.2. By Imaging Modality
        • 8.3.5.2.3. By Clinical Trial Phase
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Imaging Clinical Research Organization (CRO) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Services Offered
    • 9.2.2. By Imaging Modality
    • 9.2.3. By Clinical Trial Phase
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Services Offered
        • 9.3.1.2.2. By Imaging Modality
        • 9.3.1.2.3. By Clinical Trial Phase
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Services Offered
        • 9.3.2.2.2. By Imaging Modality
        • 9.3.2.2.3. By Clinical Trial Phase
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Services Offered
        • 9.3.3.2.2. By Imaging Modality
        • 9.3.3.2.3. By Clinical Trial Phase
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Services Offered
        • 9.3.4.2.2. By Imaging Modality
        • 9.3.4.2.3. By Clinical Trial Phase
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Imaging Clinical Research Organization (CRO) Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Services Offered
        • 9.3.5.2.2. By Imaging Modality
        • 9.3.5.2.3. By Clinical Trial Phase
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Imaging Clinical Research Organization (CRO) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Services Offered
    • 10.2.2. By Imaging Modality
    • 10.2.3. By Clinical Trial Phase
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Services Offered
        • 10.3.1.2.2. By Imaging Modality
        • 10.3.1.2.3. By Clinical Trial Phase
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Services Offered
        • 10.3.2.2.2. By Imaging Modality
        • 10.3.2.2.3. By Clinical Trial Phase
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Imaging Clinical Research Organization (CRO) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Services Offered
        • 10.3.3.2.2. By Imaging Modality
        • 10.3.3.2.3. By Clinical Trial Phase
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Imaging Clinical Research Organization (CRO) Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Services Offered
    • 11.2.2. By Imaging Modality
    • 11.2.3. By Clinical Trial Phase
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Services Offered
        • 11.3.1.2.2. By Imaging Modality
        • 11.3.1.2.3. By Clinical Trial Phase
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Services Offered
        • 11.3.2.2.2. By Imaging Modality
        • 11.3.2.2.3. By Clinical Trial Phase
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Services Offered
        • 11.3.3.2.2. By Imaging Modality
        • 11.3.3.2.3. By Clinical Trial Phase
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User
    • 11.3.4. Turkey Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Services Offered
        • 11.3.4.2.2. By Imaging Modality
        • 11.3.4.2.3. By Clinical Trial Phase
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By End User
    • 11.3.5. Egypt Imaging Clinical Research Organization (CRO) Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Services Offered
        • 11.3.5.2.2. By Imaging Modality
        • 11.3.5.2.3. By Clinical Trial Phase
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Laboratory Corporation of America Holdings
  • 14.2. IXICO PLC
  • 14.3. ICON plc
  • 14.4. The Micron Group
  • 14.5. Medpace Holdings, Inc.
  • 14.6. Radiant Sage LLC
  • 14.7. Biomedical Systems Corporation
  • 14.8. Worldcare Clinical, LLC
  • 14.9. Imaging Endpoints LLC
  • 14.10. Parexel International Corporation

15. Strategic Recommendations